CLINICAL_TRIALS
trial_result
· 2011-07-04
Clinical Trial Update: A Diabetes Study to Treat A Population Previously Not at Target [Phase 4]
Summary
AstraZeneca conducted a Phase 4 trial in Type 2 diabetes focusing on patients not at target. The results were posted in 2011.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: AstraZeneca | Conditions: Type 2 Diabetes | Phase 4 | Status: COMPLETED | Results posted: 2011-07-04